Thank you Dstock for providing the information that by the time
that Merck was involved in the combo trial, they had plenty of
information to collaborate with NWBO. By the time the combo
trial was initiated, the increased efficacy due to the addition of
poly ICLC should have been obvious and the addition of keytruda would
not seem so daunting especially if much data was also already available
from the UK Specials and Expanded Access Programs.
I do believe that within the next 6 months we will get more information
about Merck's collaboration with NWBO. I am also not excluding the
possible involvement of other actors but if true, we will get that information
as well.
Bullish